Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve {HEAD ~ therapeutic reduction} of {TAIL ~ the number} of circulating platelets 
of
Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve { HEAD ~ therapeutic reduction } of { TAIL ~ the number } of circulating platelets
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH